世界の移植片対宿主病治療薬市場...市場調査レポートについてご紹介

【英文タイトル】OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 12
1.1 List of Tables 18
1.2 List of Figures 22
2 Introduction 23
2.1 Catalyst 23
2.2 Related Reports 24
2.3 Upcoming Related Reports 24
3 Disease Overview 25
3.1 Etiology and Pathophysiology 25
3.1.1 Etiology 25
3.1.2 Pathophysiology 27
3.1.3 Classification and Prognosis 28
3.2 Symptoms 30
4 Epidemiology 32
4.1 Disease Background 32
4.2 Risk Factors and Comorbidities 33
4.3 Global Trends 35
4.4 Forecast Methodology 36
4.4.1 Sources Used 38
4.4.2 Sources Not Used 44
4.4.3 Diagnosed Incident Cases of HSCTs 45
4.4.4 Diagnosed Incident Cases of Autologous HSCTs 47
4.4.5 Diagnosed Incident Cases of Allogeneic HSCTs 48
4.4.6 Diagnosed Incident Cases of aGVHD 49
4.4.7 Four-Year Diagnosed Prevalent Cases of aGVHD 49
4.4.8 Diagnosed Incident Cases of cGVHD 50
4.4.9 Five-Year Diagnosed Prevalent Cases of cGVHD 50
4.5 Epidemiological Forecast for GVHD (2013-2023) 51
4.5.1 Diagnosed Incident Cases of HSCTs 51
4.5.2 Diagnosed Incident Cases of Autologous HSCTs 53
4.5.3 Diagnosed Incident Cases of Allogeneic HSCTs 54
4.5.4 Diagnosed Incident Cases of aGVHD 56
4.5.5 Four-Year Diagnosed Prevalent Cases of aGVHD 58
4.5.6 Diagnosed Incident Cases of cGVHD 60
4.5.7 Five-Year Diagnosed Prevalent Cases of cGVHD 61
4.6 Discussion 63
4.6.1 Epidemiological Forecast Insight 63
4.6.2 Limitations of the Analysis 64
4.6.3 Strengths of the Analysis 65
5 Current Treatment Options 66
5.1 Overview 66
5.2 Product Profiles – Major Therapies 68
5.2.1 Methylprednisolone (numerous brand and generic names) 68
5.2.2 Cyclosporine (numerous brands and generic names) 72
5.2.3 Anti-Thymocyte Globulin (ATG) Therapies 77
5.3 Product Profiles – Off-Label Therapies 82
5.3.1 Biologics (Tumor Necrosis Factor (TNF)α Inhibitors, Interleukin-2 Receptor α (CD25) Inhibitors, Co-Stimulatory Blockers and Other Biologics) 82
5.3.2 Small Immunosuppressive Molecules (mTOR Inhibitors, Solid Organ Transplant Therapies, and Anti-Neoplastic Therapies) 101
6 Unmet Need and Opportunity 116
6.1 Overview 116
6.2 Lack of Randomized Clinical Trials 119
6.2.1 Unmet Need 119
6.2.2 Gap Analysis 119
6.2.3 Opportunity 120
6.3 No Consensus Regarding Clinical Trial Endpoints 120
6.3.1 Unmet Need 120
6.3.2 Gap Analysis 120
6.3.3 Opportunity 121
6.4 Optimization of Prophylactic Measures 121
6.4.1 Unmet Need 121
6.4.2 Gap Analysis 122
6.4.3 Opportunity 122
6.5 Lack of Standardized Protocols for Established and Off-Label Therapies 123
6.5.1 Unmet Need 123
6.5.2 Gap Analysis 123
6.5.3 Opportunity 124
6.6 Improved Treatment Outcomes for Patients Who Develop Toxicities 124
6.6.1 Unmet Need 124
6.6.2 Gap Analysis 125
6.6.3 Opportunity 125
6.7 Desire for Treatments that Exhibit Longer-Lasting Efficacy Profiles 125
6.7.1 Unmet Need 125
6.7.2 Gap Analysis 126
6.7.3 Opportunity 127
6.8 Management of SR-aGVHD Patients 127
6.8.1 Unmet Need 127
6.8.2 Gap Analysis 128
6.8.3 Opportunity 128
6.9 Management of Sclerotic cGVHD Patients 128
6.9.1 Unmet Need 128
6.9.2 Gap Analysis 129
6.9.3 Opportunity 129
6.10 Improved Prognosis for Patients with Lung Involvement 130
6.10.1 Unmet Need 130
6.10.2 Gap Analysis 130
6.10.3 Opportunity 131
7 Research and Development Strategies 132
7.1 Overview 132
7.1.1 Improvement of Prophylactic Regimens 132
7.1.2 Inhibition of T-Cell Proliferation and Activation 133
7.1.3 Adopting Treatments from Hematologic Indications 134
7.1.4 Targeting Niche Subgroups Within GVHD 135
7.2 Current Clinical Trial Design 136
7.2.1 Current Trial Designs are Dependent on the Stage Within the Treatment Algorithm That a Product is Targeting 136
7.2.2 Lack of Consensus on Clinical Endpoints in Current Trial Designs 137
7.2.3 Patient Exclusion Issues in Current Trial Designs 137
7.2.4 Current Trial Design of Key Pipeline Products 137
7.3 Future Clinical Trial Design 139
7.3.1 Future Trial Designs Need to Incorporate Randomization 139
7.3.2 Future Trial Designs Need to Incorporate Conditioning Regimens and Hematological Patients 140
7.3.3 Companies Behind Off-Label Therapies Should Strategize to Conduct Randomized Studies 140
7.3.4 Design of Early-Phase Clinical Trials for Cellular and Gene Therapy Products Accommodates 2014 Guidance from the FDA 140
8 Pipeline Assessment 141
8.1 Overview 141
8.2 Promising Drugs in Clinical Development 142
8.2.1 Leukotac (inolimomab) 142
8.2.2 Begedina (BT 5/9) 147
8.2.3 Budenofalk (budesonide) 150
8.2.4 ATG-Fresenius (EZ-2053) 153
8.2.5 Prochymal (remestemcel-L) 156
8.2.6 MultiStem (modified mesenchymal stem cells) 161
8.2.7 Uvadex (Extracorporeal Photophoresis) 164
8.2.8 orBec (beclomethasone dipropionate) 168
8.3 Innovative Early-Stage Approaches 171
8.3.1 Targeting Regulatory T Cells 174
8.3.2 Mesenchymal Stem Cell Therapies 175
8.3.3 Immunomodulatory Cell Surface Receptor Inhibitors 176
8.3.4 IL-6 Inhibitors 177
9 Pipeline and Off-Label Valuation Analysis 178
9.1 Clinical Benchmarking of Key Pipeline and Off-Label Drugs 178
9.1.1 GVHD Prophylaxis 178
9.1.2 Acute GVHD 181
9.1.3 Chronic GVHD 185
9.2 Commercial Benchmarking of Key Pipeline and Off-Label Drugs 186
9.2.1 GVHD Prophylaxis 187
9.2.2 Acute GVHD 189
9.2.3 Chronic GVHD 191
9.3 Competitive Assessment 193
9.3.1 GVHD Prophylaxis 193
9.3.2 Acute GVHD 194
9.3.3 Chronic GVHD 196
9.4 Top-Line Five-Year Forecast 198
9.4.1 US 203
9.4.2 5EU 207
10 Appendix 211
10.1 Bibliography 211
10.2 Abbreviations 230
10.3 Methodology 236
10.4 Forecasting Methodology 236
10.4.1 Diagnosed GVHD Patients 236
10.4.2 Percent Drug-Treated Patients 237
10.4.3 Drugs Included in Each Therapeutic Class 237
10.4.4 Launch and Patent Expiry Dates 238
10.4.5 General Pricing Assumptions 238
10.4.6 Individual Drug Assumptions 239
10.4.7 Generic Erosion 246
10.4.8 Pricing of Pipeline Agents 246
10.5 Physicians and Specialists Included in This Study 247
10.6 About the Authors 249
10.6.1 Author 249
10.6.2 Reviewer 249
10.6.3 Epidemiologist 250
10.6.4 Global Head of Healthcare 250
10.7 About GlobalData 251
10.8 Disclaimer 251


【レポート販売概要】

■ タイトル:世界の移植片対宿主病治療薬市場
■ 英文:OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018
■ 発行日:2014年8月20日
■ 調査会社:GlobalData
■ 商品コード:GDHC021POA
■ 調査対象地域:グローバル
  • Wright Medical Group, Inc.:市場シェア分析
    Wright Medical Group, Inc. Market Share Analysis Summary GlobalData’s new report, “Wright Medical Group, Inc. Market Share Analysis” provides in-depth information on Wright Medical Group, Inc.’s market position in the different medical equipment markets it operates in. The report provides Wright Medical Group, Inc. market share information in five key market categories – Other Joint Reconstruction …
  • 航空機用ベアリングの世界市場予測(~2022年):ころ軸受、玉軸受
    The aerospace bearings market is projected to grow from USD 7.88 Billion in 2016 to USD 11.19 Billion by 2022, at a CAGR of 6.01% during the forecast period. Factors such as increase in aircraft orders and deliveries across the globe, and upgradation of aircraft to reduce operational cost are the major growth factors for the aerospace bearings market. The market has been segmented on the basis of …
  • 中国のCOPD治療薬市場2016-2020
    About the Chronic Obstructive Pulmonary Disease (COPD) Drugs Market in China Chronic obstructive pulmonary disease (COPD) is a broad term that covers progressive lung diseases, including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It restricts airflow in the lungs and is characterized by diffculty breathing. The exact etiology of COPD is not …
  • 世界の電気自動車(EV)充電器市場(2014-2018)
    About Charging Equipment for Electric Vehicles Electric vehicle charging equipment, also called EV charging station, electric recharging point, and charging point, is an important element in an infrastructure that supplies electric energy for the recharging of plug-in electric vehicles, including all-electric cars, neighborhood electric vehicles and plug-in hybrids. The equipment are broadly divid …
  • 食品包装の世界市場:包装材料(紙、ボード、プラスチック、ガラス、金属)、種類、用途別分析
    Packaging materials deliver functional, aesthetic, and sustainability benefits to consumers. Food packaging provides protection, tampering resistance, maintains the sensory quality of food, and also increases the shelf-life of products. The packaging material used depends on the functional properties of the food. Changing consumer lifestyle and the choice of convenient foods increases the demand f …
  • 自動車用イベントデータレコーダー(EDR)の世界市場2017-2021
    About Automotive Event Data Recorder An EDR is a device installed in a vehicle for recording the operation of vehicle systems for a few seconds (close to 20 seconds) during the time of occurrence of an accident. The recordings are predominantly used for assessing the functioning and effectiveness of vehicle systems during and after accidents. It is imperative to note that neither can the data in E …
  • 二つ折り扉の世界市場
    About Bifold DoorsA bifold door is a type of closet door having two or more individual door panels, conjoined with hinges, which operate on a sliding track. However, bifold doors do not include overlapping sliding doors. Technavio’s analysts forecast the global bifold doors market to grow at a CAGR of 4.68% during the period 2017-2021. [Covered in this report] The report covers the present scenari …
  • 2G/3G/4Gセルラー・ネットワーク加入者データベース(2G, 3G & 4G Cellular Network Subscriptions Database Q1’2012)
    With 6.1 billion global cellular network subscriptions, the year 2011 has seen mobile penetration levels reach over 87 %. From an operator perspective, China Mobile is leading the market with over 650 million subscriptions. Indian operators (primarily Bharti, Vodafone, Reliance, Idea Cellular, BSNL etc) also constitute a considerable market share with over 928 million subscriptions. Mobile broadba …
  • 照明及びディスプレイ分野における量子ドットの市場機会
    ※当レポートは量子ドット(QD)のビジネス機会、競合材料との比較、最新製品、メーカーの戦略と技術開発などをまとめました。 This new NanoMarkets report provides an in depth market analysis of the opportunities emerging within the field of quantum dots (QDs), examining the latest products, strategies and technical developments in electronics applications for these emerging materials. Within the report we assess how QDs are likely to penetrate addressable marke …
  • 世界の人工衛星市場動向(2014-2018)
    TechNavio's analysts forecast the Global Satellite market to grow at a CAGR of 8.05 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing Commercial Satellite market. The Global Satellite market has also been witnessing the increasing demand for high power and high throughput satellites. However, the decreasing government space funding could po …
  • 希土類金属の世界市場2017-2021
    ABSTRACTAbout Rare Earth Metals Rare earth metals comprise 17 chemical elements in the periodic table, which include fifteen elements of the lanthanide series, and scandium and yttrium. Scandium and yttrium are also considered rare earth metals as they are found in the same mineral ore deposits as the other elements of the lanthanide series. Rare earth metals have unique physical and chemical prop …
  • キャンプファイヤー用三脚の世界市場
    ABSTRACTAbout Camp Fire Tripod A tripod is used over a campfire or fire pit to hang different cooking equipment over the fire. These tripods are equipped with a chain to hold the pot or grillers. It can be raised to the desired height over the fire to fine-tune the cooking temperature. It helps in efficient and even cooking and is lighter in weight than a fire grill. In addition to the table grate …
  • 分散型音響センシング(DAS)の世界市場2016-2020
    About Distributed Acoustic Sensing In 2015, the oil and gas sector was the highest contributor to the overall market, with a 53.73% market share. The oil and gas industry is a growing industry with increasing demands for unconventional resources and is expected to increase its market presence in the global market. The oil and gas industry is likely to continue to dominate the market during the for …
  • 光干渉断層画像診断法(OTC)の世界市場2017-2021
    About OCT OCT can help to identify diseases such as diabetic retinopathy and glaucoma at the granular level by providing the images of the retina in layers, which can help physicians identify the disease and form a treatment plan. Technavio’s analysts forecast the global OCT market to grow at a CAGR of 8.16% during the period 2017-2021. [Covered in this report] The report covers the present scenar …
  • シップローダの世界市場
    About Ship LoadersShip loader is a port material handling equipment used for bulk material loading application. The growth in the bulk cargo transportation and the mining industries exploration activities drive the demand for ship loaders. Most common dry bulk materials such as coal, iron ore, grains, fertilizers, and any powder or granular dry cargo material use ship loaders for loading applicati …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。